CBX3 and non-small cell lung carcinoma: Zhou et al. [13], Han et al. [17] and Chang et al. [11] also found CBX3 to be overexpressed in NSCLC, and Zhou et al. [13] further confirmed that CBX3 is an independent prognostic biomarker for NSCLC.